RT Journal Article
SR Electronic
T1 Conflicts of interest and physicians’ attitudes towards hydroxychloroquine as a treatment against COVID-19 A replication and extension of Roussel & Raoult (2020)
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.10.18.21265135
DO 10.1101/2021.10.18.21265135
A1 Louis Freget
A1 Matthieu Mulot
A1 Michael Rochoy
A1 Valentin Ruggeri
A1 Céline Schöpfer
A1 Florian Cova
YR 2021
UL http://medrxiv.org/content/early/2021/10/25/2021.10.18.21265135.abstract
AB Hydroxychloroquine (HCQ) and its use as a treatment against COVID-19 have been at the center of heated debates. Some claim that physicians’ hostility towards HCQ was partly orchestrated by rival pharmaceutical companies seeking to promote their own treatment. In favor of this hypothesis, Roussel and Raoult (2020) have presented the results of a study in which they find a perfect positive correlation (ρ = 1.00) between French physicians’ attitudes towards HCQ and their conflict of interest with Gilead Sciences - the company that has promoted Remdesivir (REM) as a treatment against COVID-19. However, Roussel and Raoult’s study suffers from serious methodological shortcomings, among which is the fact that the statistical methods they employed might tend to artificially inflate correlations. In this study, we use a similar method and sample, but correct for their study’s original shortcomings: we provide a detailed, pre-registered method for collecting and coding data, computer inter-rater agreement and use a wide array of appropriate statistical methods to achieve a more reliable estimate the association between conflicts of interest and physicians’ attitudes towards HCQ. We conclude that Roussel and Raoult’s conclusion was misguided and that financial conflicts of interest were not the main predictors of the attitudes of physicians when compared to other factors, such as academic affiliation. Moreover, compared to other pharmaceutical companies, there was no specific link between attitudes towards HCQ and conflicts of interest with Gilead Sciences.Competing Interest StatementThe authors have declared no competing interest.Funding StatementAll the authors but one did not receive fundings for this project. Florian Cova received a grant from the Swiss National Science Foundation: "Eudaimonic emotions and the (meta)philosophy of well-being"Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study includes funding data of physicians which is openly available on eurofordocs.eu. The list of physicians is available here: https://www.infectiologie.com/fr/organigramme-cmit.htmlI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced are available online at: osf.io/uahq6/